98 BLA 125742 0 08 19 2021 Telecon Labeling via FAX e

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

From:  Gottschalk, Laura <[email protected]>  
Sent:  Thursday, August 19, 2021 12:54 PM  
To: Harkins Tull, Elisa <[email protected]>  
Cc: Devlin, Carmel M <[email protected]>; Aghajani Memar, Neda 
<[email protected]>; Smith, Michael (CBER) <[email protected]>; Naik, 
Ramachandra <[email protected]>  
Subject:  STN 125742.0: 6th set of PI labeling comments - please respond by COB today  
 Dear Elisa,  
 Attached is the 6
th set of comments from the review team on the Package Insert (PI). Please email us the 
further revised PI (both Word tracked- changes and Word annotated) by COB today, August 19, 2021, 
and follow up with a submission to the BLA.  
 Please acknowledge receipt and let me know if you have any questions.  
 
Best,  
Laura  
 
Laura Gottschalk, PhD  
Regulatory Project Manager/Primary Reviewer    
Center for Biologics Evaluation and Research  
Office of Vaccines Research and Review  
U.S. Food and Drug Administration 
Tel: 301 -796- 0798 
[email protected]  
 
 
         
 
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW.   If you are not 
the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, disseminatio n, copying, or other action based on the content of this communication is not authorized.   If you 
have received this document in error, please immediately notify the sender by e- mail or phone.  
 
 
FDA-CBER-2021-5683-1024834